Skip to main content
Clinical Trials/DRKS00013778
DRKS00013778
Completed
Not Applicable

Predictive markers for progessive disease progression in Acne Inversa (AI)/Hidradentitis Suppurativa (HS) patients - PIRANHA

AbbVie Deutschland GmbH Co. KG0 sites481 target enrollmentJanuary 26, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ACNEINVERSA
Sponsor
AbbVie Deutschland GmbH Co. KG
Enrollment
481
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 26, 2018
End Date
June 30, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with confirmed diagnosis of acne inversa/ Hidradenitis suppurativa

Exclusion Criteria

  • Illiteracy or language skills not sufficient (German), in order to fill the questionnaires

Outcomes

Primary Outcomes

Not specified

Similar Trials